Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been postulated that the high levels of autoantibodies observed in
systemic lupus erythematosus
(
SLE
) patients could result from abnormal longevity of polyclonally activated B-cells. This increased survival could be due to dysfunction of apoptosis, the normal regulatory process governing their life span. The protein product of the bcl-2 gene can enhance lymphoid cell survival by interfering with apoptosis. Moreover, transgenic mice overexpressing bcl-2 in their B-cells developed an autoimmune syndrome resembling
SLE
. To determine whether overexpression of bcl-2 occurs in
SLE
patients, bcl-2 protein was measured in peripheral blood mononuclear cells from 73
SLE
patients, 20 healthy individuals and 47 patients with other autoimmune diseases. Only three
lupus
patients had raised levels of bcl-2 and there were no statistically significant differences in the mean bcl-2 levels measured in
SLE
patients compared to controls.
Bcl-2
levels did not correlate with overall disease activity in
SLE
patients.
...
PMID:Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus. 778 44
The bcl-2 gene was first discovered by molecular analysis of the 14;18 chromosome translocation which is the hallmark of most cases of human follicular lymphoma. To date, it is unique among proto-oncogenes because, rather than promoting cell proliferation, it fosters cell survival. This review summarizes the impact of constitutive bcl-2 expression on the development and function of lymphocytes as well as their malignant transformation. Expression of a bcl-2 transgene in the B lymphoid compartment profoundly perturbed homeostasis and, depending on the genetic background, predisposed to a severe autoimmune disease resembling human
systemic lupus erythematosus
. T lymphoid cells from bcl-2 transgenic mice were remarkably resistant to diverse cytotoxic agents. Nevertheless, T lymphoid homeostasis was unaffected and tolerance to self was maintained. Expression of high levels of
Bcl-2
facilitated the development of B lymphoid tumours but at relatively low frequency and with long latency. Co-expression of myc and bcl-2, on the other hand, promoted the rapid onset of novel tumours which appeared to derive from a lympho-myeloid stem or progenitor cell. Introduction of the bcl-2 transgene into scid mice facilitated the survival and differentiation of pro-B but not pro-T cells, suggesting that a function necessary to supplement or complement the action of
Bcl-2
is expressed later in the T than the B lineage. Crosses of the bcl-2 transgenic mice with p53-/- mice have addressed whether loss of p53 function and gain of bcl-2 function are synergistic for lymphoid cell survival.
...
PMID:Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells. 784 27
Antigen-activated T cells of the CD4(+)CD8(-) phenotype are susceptible to antigen receptor-stimulated cell death. This form of apoptotic cell death has been shown to be dependent on the expression of the Fas (CD95) antigen and can occur via an autocrine mechanism involving the concomitant up-regulation of Fas and its ligand on activated T cells. Mutation in genes encoding Fas (Ipr) and the Fas ligand (gld) contribute to the development of an autoimmune syndrome similar to
systemic lupus erythematosus
in mice. These observations led to the suggestion that the Fas signaling pathway is an important regulator of immune responses in vivo. Here we evaluated the importance of the Fas pathway in regulating immune responses by male antigen-specific CD4(-)CD8(+) T cells. We found that the in vivo elimination of these activated cells was independent of Fas expression by these cells. However, the elimination of these activated cells was inhibited by the transgenic expression of
Bcl-2
, a protein that inhibits multiple forms of apoptotic cell death. The transgenic
Bcl-2
protein also inhibited the death of male antigen-activated cells following IL-2 deprivation. Cell death resulting from IL-2 deprivation occurred efficiently in male antigen-activated Fas- cells. We propose that the rapid deletion of male antigen-activated Fas- cells in vivo is due to limiting amounts of IL-2 that are available in the microenvironment of the activated cells at the peak of the response.
...
PMID:Fas (CD95)-independent regulation of immune responses by antigen-specific CD4-CD8+ T cells. 867 54
CD28 on T cells provides a potent costimulatory signal for T cell activation. Down-regulation of CD28 on peripheral T cells has been reported in certain clinical conditions, but full studies on the mechanism and biological significance have not been performed. Our extensive phenotype analysis of peripheral blood lymphocytes (PBL) from
SLE
patients revealed that the absolute number of CD28+ T cells of both CD4 and CD8 phenotypes was selectively decreased, while that of CD28- T cells was maintained. CD28+ T cells from
SLE
patients exhibited mostly normal proliferative responses to both CD28-dependent and -independent stimulations. In contrast, CD28- T cells were hyporesponsive to anti-CD3 stimulation in both
SLE
and normal controls. These results implied that the selective decrease of CD28+ T cells in
SLE
does not result from a hyporesponsiveness of CD28+ T cells. To investigate the reason for the selective loss of CD28+ T cells, we determined the appearance of apoptotic cells in culture with or without anti-CD3 stimulation. Apoptotic cells defined by merocyanine (MC)540 were gradually increased from 12 h to 24 h. Anti-CD3-induced apoptosis of CD28+ T cells was significantly accelerated in
SLE
, whereas apoptosis of CD28- T cells was hardly detected in both
SLE
and normal controls. Comparative analysis between CD28+ and CD28- T cells on CD95 (Fas) and
Bcl-2
expression, which are related to activation-induced cell death (AICD), did not show a major difference, although CTLA4, which has been demonstrated to transmit an apoptosis-inducing signal, was expressed only on CD28+ T cells. Our results suggest that CD28-mediated costimulation influences T cell susceptibility to AICD and may be involved in T cell lymphopenia in
SLE
.
...
PMID:Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. 891 66
Accelerated apoptosis and improper expression of cytokine genes have been considered as important defects of lymphocytes for the development of
systemic lupus erythematosus
(
SLE
). This study was undertaken to test the possible contribution of serum factors obtained from
SLE
patients to these abnormalities. Molt-4 and Jurkat cells constantly exhibited a slower growth rate as well as more dead cells in culture with
SLE
sera tested than controls, although the cell cycle progression was apparently unaffected. Increased apoptosis was demonstrable among
SLE
sera-cultured cells by ELISA for apoptosis-specific DNA fragments and terminal deoxynucleotidyl transferase (TdT) in situ death analysis. Different levels of Fas, Fas-L, and
Bcl-2
gene products were not detected between
SLE
sera-treated cells and the controls. The transcripts of interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) genes of these two T cell lines were evidently increased in the presence of
SLE
sera, while IL-2 and IL-4 were unaffected. Elevated expression of IL-5 was also found in Molt-4 cells. By contrast,
SLE
sera reduced the transcripts of IL-6 gene in Jurkat cells. The effects of
SLE
sera were independent of corticosteroid medication. These results suggest that serum abnormalities may also play a role in T cell dysfunction.
...
PMID:Induction of apoptosis and cytokine gene expression in T-cell lines by sera of patients with systemic lupus erythematosus. 901 May 6
Programmed cell death, an essential function in all cells, plays a central role in maintaining immune system homeostasis and controlling autoimmune reactions. Cell death may be an essential element in
disseminated lupus erythematosus
: defective cell death could lead to the development of autoreactive lymphocyte clones and degradation products of cell death could be implicated in autoimmunity induction and onset of renal lesions. Anomalies in programmed cell death have been demonstrated in murine models of
lupus
: mutations of the fas and fas-ligand genes, which play a known role in programmed cell death, produce the lpr and gld phenotypes associating lymphoproliferation and
lupus
. Transgenic mice which express
Bcl-2
(the product of
Bcl-2
inhibits programmed cell death) on B lymphocytes develop a
lupus
-type autoimmune disease. The role of these types of anomalies in human disease is not yet elucidated. However, cell death, via the degradation fragments of chromatin, could play a role in inducing antibody production and development of renal lesions. The anti-DNA antibodies, with characteristic antigen-induced immune response (clone expansion, class computation and somatic mutations) could be induced by nucleosomes released during cell death. Several arguments favor this mechanism including cation residues of histone nucleosomes which would bind to anionic residues of sulfate heparan and lead to deposit of autoantibodies in the glomerulus. The dual role of cell death is not really contradictory in autoimmune disease controlled by several independent genes, but would be compatible with several different genetic backgrounds.
...
PMID:[Cell death and lupus]. 909 57
Systemic lupus erythematosis
(
SLE
) is a multifactorial disease with both genetic and environmental etiology. The complexity of factors contributing to
SLE
are considered in an analogy with a card game. The hears suit represents sex hormones.
SLE
is a disease of marked female prevalence and abnormal estrogen metabolism has been described in women with
SLE
. The clubs suit considers complement and other genetic factors. Increased risk of
SLE
has been described in association with some HLA markers and the complement C4A0 null allele. Although convincing evidence has not yet emerged, other candidate genes of importance are T cell receptor genes and genes encoding B cell immunoglobulin receptors and antibodies. Recently, abnormalities of apoptosis and of expression of the protooncogene
Bcl-2
have been investigated. Overall different genes have been shown to increase the risk of
SLE
, and/or to influence the development of particular antibodies, and particular subsets of disease. The diamonds suit considers antigens and antibodies in the etiopathogenesis of
SLE
. Numerous autoantibodies have been described that bind a variety of targets on the cell surface, within the cytoplasm, or in the nucleus. It is generally agreed that autoantibodies develop as a consequence of both generalized polyclonal activation and antigen drive. The final suit of spades considers infectious, environmental, and other agents such as drugs, as triggers in the development of
SLE
.
...
PMID:Systemic lupus erythematosus: immunopathogenesis and the card game analogy. 915 Jan 21
An important prerequisite for a successful pregnancy is that the maternal immune system does not reject the fetus. Down-regulation of the T helper 1 (TH1) associated cellular immune response could therefore be essential. With flow cytometric techniques, we show on a single cell level that both CD4+ and CD8+ T cells from peripheral blood produce less TH1 cytokines (i.e. IFN-gamma and IL-2) and more TH2 cytokines (i.e. IL-4) during normal human pregnancy and shortly after delivery than during non-pregnancy. The TH1/TH2 cytokine ratio in T cells of women during pregnancy and after delivery was significantly decreased. In contrast the TH1/TH2 ratio was elevated to near normal in women with recurrent spontaneous abortions, indicating a marked shift towards TH1 immunity. Fas antigen (CD95) on T cells was significantly elevated during pregnancy and in the post-delivery phase whereas the intracellular expression of anti-apoptotic protein
Bcl-2
remained unchanged. Nevertheless Fas-mediated apoptosis in T cells was markedly reduced during normal human pregnancy. We hypothesize that TH1 cells undergo predominantly Fas-mediated apoptosis during pregnancy as has been shown in some TH2-prone diseases (e.g.
SLE
, HIV) where an elevated Fas expression on peripheral T cells is observed. This could explain the exacerbated occurrence of TH2-associated diseases in pregnancy.
...
PMID:Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. 958 18
Although cumulative evidence suggests that a genetic predisposition plays a major role in development of
systemic lupus erythematosus
(
SLE
) and/or lupus nephritis (LN), the susceptibility genes are mostly unknown. The difficulty in identifying susceptibility genes is due in part to multiple genes with variable genetic effects and the diverse genetic backgrounds of human populations. In human
SLE
, genes of early components of complements as well as many polymorphic genes (including the MHC class II and class III, FcgammaR, mannose-binding protein, IL-6,
Bcl-2
, and IL-10 genes) have been associated with
SLE
or LN by population-based case-control or within-case studies. The contribution of some of these disease-associated genes to the presence or absence of clinical manifestations has been further tested in mice with targeted disruption of the specific candidate gene. In addition to
SLE
susceptibility genes, there may be a separate set of nephropathy susceptibility genes predisposing to LN as suggested by the familial clustering of end-stage renal disease in African-Americans with LN. The availability of densely mapped genetic markers spanning the entire genome has enabled the identification of chromosomal regions linked to disease susceptibility genes without prior knowledge of the gene function. Our group has used known murine
lupus
susceptibility loci as a guide, and conducted linkage analysis of genetic markers located within a specific, possibly syntenic human chromosomal region. Evidence for linkage of a chromosome 1q41-42 region was observed in
SLE
-affected sib pairs from multiple ethnic groups. More recently, several groups have reported results of genome scans of
SLE
-affected sib pairs or pedigrees. These exciting recent developments in delineating the genetic basis of
SLE
or LN are summarized in this review.
Lupus
1998
PMID:Genetic susceptibility to lupus nephritis. 988 94
Keratinocyte apoptosis may be induced by ultraviolet-B radiation and represents a potential source of fragmented autoantigens in autoimmune diseases. This study investigates whether excessive keratinocyte apoptosis occurs in the skin lesions of cutaneous
lupus
(CLE) and dermatomyositis (DM) and the potential mechanisms responsible for this phenomenon. Skin biopsies have been studied from 19 patients with CLE and DM, eight with scleroderma, and five healthy controls. Apoptosis was detected by in situ end-labelling of fragmented DNA. The expression of
Bcl-2
, PCNA, p53, and Ki-67 proteins was studied by immunohistochemistry. In DM and CLE skin, the number of apoptotic keratinocytes was significantly increased (p=0.008) compared with normal skin. In both diseases, a large accumulation of apoptotic keratinocytes and apoptotic bodies was present in the disrupted basal zone. Unlike normal skin, a large number of keratinocytes, particularly those morphologically apoptotic, expressed p53 protein. A significant increase in the number of proliferating Ki-67 positive (p=0.0007) and PCNA-positive (p=0.0008) nuclei was also observed. In both CLE and DM, exaggerated and inappropriate keratinocyte apoptosis occurs. It is associated with increased expression of p53 and PCNA. This suggests that normal solar radiation alone or in combination with additional local factors induces DNA damage and excessive keratinocyte apoptosis in these autoimmune diseases of the skin. Apoptosis can mediate the severe epidermal lesions observed in both diseases and the release of fragmented autoantigens into the dermis.
...
PMID:Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. 1039 42
1
2
3
4
5
6
7
8
Next >>